Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thrombocythemia, Essential × Drug Therapy × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 9 Neoplasm Metastasis 4 Lung Neoplasms 4 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Ovarian Neoplasms 3 Leukemia, Myeloid, Acute 3 Head and Neck Neoplasms 3 Fallopian Tube Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Colorectal Neoplasms 2 Anus Neoplasms 2 Urinary Bladder Neoplasms 1 Tobacco Use Disorder 1 Smoking Cessation 1 Select Advanced Solid Tumors 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Pancreatic Intraductal Neoplasms 1 Oropharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Muscle-invasive Bladder Cancer 1 Mouth Neoplasms 1 Lymphoma, Large B-Cell, Diffuse 1

Interventions

ruxolitinib 3 venetoclax 1 veliparib 1 pevonedistat 1 iadademstat 1 fedratinib 1 decitabine and cedazuridine drug combination 1 bomedemstat 1 Topotecan 1 Specimen Handling 1 Injections 1 INCB057643 1 Decitabine 1 Carboplatin 1 Biopsy 1 Azacitidine 1 Acetylcysteine 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡